Abstract
A 67-year-old man, who had received intermittent courses of oral chlorambucil and prednisone as therapy for chronic lymphocytic leukaemia over a period of 3.5 years, developed fatal lung fibrosis. A case report and brief reviewof the current data on chlorambucil-induced lung disease are presented.
| Original language | English |
|---|---|
| Pages (from-to) | 156-158 |
| Number of pages | 3 |
| Journal | Acta Haematologica |
| Volume | 83 |
| Issue number | 3 |
| DOIs | |
| Publication status | Published - 1990 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Chlorambucil
- Chronic lymphocytic leukaemia
- Lung fibrosis
Fingerprint
Dive into the research topics of 'Chlorambucil lung toxicity'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver